Cardiac Monitors

Policy ID: M-50-035

Section: Diagnostic Medical

Effective Date: July 01, 2018

Revised Date: June 02, 2021

Revision Effective Date: July 01, 2021

Last Reviewed: July 22, 2021

Description

Ambulatory Cardiac Monitors:

Monitors activated only when triggered by the individual:

These monitors are often referred to as event monitors. The two (2) basic types are:
- Looping memory monitor: activated by pushing a button; stores data from before and during symptom occurrence, prior to when it was activated; if activated immediately after a syncopal episode, it will record from the time before the event;
- Symptom event monitor: activated by pushing a button; does not store data prior to when it was activated.

ZIO Patch:

An external monitor applied by adhesive to the chest; it records continuously and typically is worn up to 14 days. It is much less expensive than the mobile cardiac output telemetry and the implantable monitors.

Mobile Cardiac Outpatient Telemetry (MCOT):

A type of loop monitor that is auto-triggered by rhythm changes and also can be triggered by the individual. It is commonly ordered for 14 or 30 day periods.

Implantable Cardiac Monitor:

A monitor implanted under the skin that can monitor continuously and can be triggered by the individual; it may be implanted for several years.

Criteria

Coverage is subject to the specific terms of the member’s benefit plan.

Ambulatory Cardiac Monitors

The use of individual activated or auto activated external ambulatory event monitors or continuous ambulatory monitors that record and store information for periods greater than 48 hours may be considered medically necessary as a diagnostic alternative to Holter monitoring.

Quantity Level Limits (QLL)

Ambulatory event monitors may be considered medically necessary once in a 30 day period regardless of the number of events or recordings which occurred. Ambulatory event monitors are considered part of the global allowance and are not eligible for separate reimbursement when performed more frequently within the 30 day period.
Ambulatory event monitors for greater than 30 consecutive days in a twelve (12) month period must be referred for a medical necessity determination. An additional 30 consecutive days may be considered medically necessary in EITHER of the following situations:
- After treatment has been initiated, the symptoms continue to occur; or
- No symptoms occurred during the initial 30 day use of the recorder.

Additional use greater than 30 consecutive days can be made only if documentation can establish the medical need for the frequency.

The use of individual activated or auto activated external ambulatory event monitors or continuous ambulatory monitors not meeting the criteria as indicated in this policy is considered not medically necessary.

Procedure Codes

93268

93270

93271

93272

Ambulatory Cardiac Monitoring (ZIO Patch) and Event Monitors

The use of long-term (greater than 48 hours) external ECG monitoring by continuous rhythm recording and storage (e.g., Zio Patch) may be considered medically necessary for EITHER one of the following:

Individuals who experience infrequent symptoms (less frequently than every 48 hours) suggestive of cardiac arrhythmias (i.e., palpitations, dizziness, presyncope, or syncope); or
Individuals with atrial fibrillation (AF) who have been treated with catheter ablation and in whom discontinuation of systemic anticoagulation is being considered.

The use of long-term (greater than 48 hours) external ECG monitoring by continuous rhythm recording and storage not meeting the criteria as indicated in this policy is considered not medically necessary.

Procedure Codes

93241	93242	93243	93244	93245	93246	93247
93248

Mobile Cardiac Outpatient Telemetry (MCOT)

MCOT is limited to a select population and may be considered medically necessary when ALL of the following are met:

The individual has failed the following:
- 48 hour Holter monitor AND/OR it is felt that longer monitoring is necessary; and
- ZIO patch; or
- Individual-triggered event monitor; or
The individual’s condition is such that a Holter monitor OR an event monitor OR a Zio Patch is NOT adequate to make a diagnosis. An explanation must be provided as to why ONLY the MCOT would be sufficient; and
There is low likelihood of a malignant cardiac event; and
Individuals who experience infrequent symptoms (less than every 24-48 hours) suggestive of cardiac arrhythmias (i.e., palpitations, dizziness, presyncope, or syncope); and
It is anticipated that the results of this service would provide diagnostic and treatment information; and

ANY of the following:

Individuals who require monitoring for known, non-life-threatening arrhythmias, such as AF, other supra-ventricular arrhythmias, evaluation of various bradyarrhythmias and intermittent bundle branch block; or
Individuals recovering from cardiac surgery who have documented atrial arrhythmias; or
Individuals with symptomatic underlying structural disease; or
Individuals with no structural heart disease but have recurrent severe symptoms (i.e., recurrent syncope), all testing is negative and an implantable event recorder is contemplated; or
Individuals with unexplained syncope, near syncope, or episodic dizziness; or
Individuals with unexplained recurrent palpitations; or
Individuals with unexplained recurrent shortness of breath; or
Individuals with unexplained recurrent chest pain; or
Individuals with a history of acute myocardial infarction (MI); or
Individuals who require evaluation of antiarrhythmic drug therapy.

Contraindications

Real-time outpatient cardiac monitoring is contraindicated for individuals at high risk of developing sustained ventricular tachycardia or ventricular fibrillation and/or would be more appropriately cared for in a hospital setting.
The MCOT is not indicated for individuals with mild to moderate symptoms of "palpitations" or "weakness."
This system is also not indicated for use as a screening tool.

Use of cardiac surveillance and Holter or event monitoring for the same individual on the same day is considered not medically necessary.

The use of MCOT not meeting the criteria as indicated in this policy is considered not medical necessary.

QLL

MCOT is considered not medically necessary when more than one (1) monitoring episode is reported in a 30 day period.
MCOT is considered not medically necessary when more than two (2) monitoring episodes are reported in a (12) month period.

Procedure Codes

93228

93229

Implantable Cardiac Loop Recorder

The implantation and removal of a cardiac loop recorder may be considered medically necessary when an individual meets the following:

The individual has failedthe following:

48 hour Holter monitor AND/OR it is felt longer monitoring is necessary; and
A ZIO patch; or
An individual-triggered event monitor; or
The individual’s condition is such that those devices are not adequate to make a diagnosis and
There is documentation of the following:
- Palpitations; or
- Dizziness; or
- Syncope and collapse; or
- Other transient symptoms which could be due to arrhythmia; or
- Long term cardiac monitoring post cryptogenic stroke or transient ischemic attack (TIA) ; and
- When BOTH of the following criteria are met:
  - A cardiac arrhythmia is suspected as the cause of the symptoms; and
  - EITHER of the following criteria are met:
    - Individuals with heart failure, prior MI or significant ECG abnormalities, noninvasive ambulatory monitoring, consisting of 30- day presymptom external loop recordings or MCOT, fails to establish a definitive diagnosis; or
    - Individuals without heart failure, prior MI or significant ECG abnormalities, symptoms occur so infrequently and unpredictably (less than one (1) per month) that noninvasive ambulatory monitoring (MCOT or external loop recorders) are unlikely to capture a diagnostic ECG.

The use of an implantable cardiac loop recorder not meeting the criteria as indicated in this policy is considered not medically necessary.

QLL

A remote interrogation device evaluation may be considered medically necessary once in 30 days with interim physician analysis and review.

Procedure Codes

0650T	33285	33286	93285	93291	93297	93298
E0616	G2066

Implantable Cardiac Loop Recorder for Post Cryptogenic Stroke or TIA

An implantable cardiac loop recorder, for post cryptogenic stroke or TIA, may be considered medically necessary when ALL of the following are met:

Diagnosis of a cryptogenic ischemic stroke or TIA should be based upon evaluation by a neurologist; and
The following standard tests are ALL required to establish diagnosis of cryptogenic stroke:
- Brain MRI or CT; and
- 12 lead ECG for AF detection; and
- 24 hour ECG monitoring for AF detection (e.g. Holter); and
- Transesophageal echocardiography (TEE); and
- CT angiography (head and neck) or magnetic resonance angiography (MRA) (head and neck) to rule out other causes of stroke; and
The individual is greater than or equal to 40 years of age; and
A documented collaborative treatment plan between neurologist and cardiologist; and
A TIA requires additional documentation of speech disturbance or limb weakness.

Not Medically Necessary

Implantable cardiac loop recorders post cryptogenic stroke or TIA are considered not medically necessary if an individual has ANY of the following:

The individual has a known etiology of stroke or TIA (i.e., large artery atherosclerosis, acute small artery occlusion with a lesion less than one (1) cm in diameter by CT or MRI; or
Evidence of high-risk cardiac or aortic arch source of embolism (left ventricular (LV) or left atrial (LA) thrombus) or ”smoke”, emboligenic valvular lesion or tumor, patent foramen ovale (PFO) with extant source of venous thromboembolism, aortic arch plaque greater than three (3) mm thick or with mobile components; or
History of spontaneous deep vein thrombosis (DVT); or
Stroke of other determined cause such as the presence of non-atherosclerotic vasculopathy, hypercoagulable states (must be tested in individuals less than 55 years of age) and hematologic disorders; or
Untreated hyperthyroidism; or
MI less than one (1) month before stroke/TIA; or
Coronary bypass grafting (CABG) less than one (1) month before stroke/TIA; or
Valvular disease requiring immediate surgical intervention; or
Documented history of AF or atrial flutter; or
Presence of PFO and PFO is an indication to start oral anticoagulant therapy in accordance with European Stroke Organization (ESO) guidelines; or
The individual has a permanent indication for anticoagulation; or
The individual has a permanent contraindication for anticoagulation; or
Life expectancy less than one (1) year; or
The individual is indicated for implant with pacemaker, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy (CRT) or implantable hemodynamic monitoring system.

An implantable cardiac loop recorder, for post cryptogenic stroke or TIA not meeting the criteria as indicated in this policy is considered not medically necessary.

Procedure Codes

0650T

33285

33286

E0616

Diagnosis Codes

Covered Diagnosis Codes for procedure codes 93268, 93270, 93271, and 93272

I25.111	I25.118	I25.119	I25.701	I25.708	I25.709	I25.711
I25.718	I25.719	I25.721	I25.728	I25.729	I25.731	I25.738
I25.739	I25.751	I25.758	I25.759	I25.761	I25.768	I25.769
I25.791	I25.798	I25.799	I46.2	I46.8	I46.9	I47.0
I47.2	I49.3	I49.01	I49.02	I50.1	Q24.6	Q25.21
Q25.29	Q25.40	Q25.41	Q25.42	Q25.43	Q25.44	Q25.45
Q25.46	Q25.47	Q25.48	Q25.49	R06.3	R06.83	R06.89
R07.82	R40.4

Covered Diagnosis Codes for procedure codes 93228, 93229, 93268, 93270, 93271, and 93272

I20.1	I20.8	I20.9	I44.0	I44.1	I44.2	I44.4
I44.5	I44.7	I44.30	I44.39	I44.60	I44.69	I45.0
I45.2	I45.3	I45.4	I45.5	I45.6	I45.10	I45.19
I45.89	I47.1	I47.9	I48.0	I48.11	I48.19	I48.20
I48.21	I48.3	I48.4	I48.91	I48.92	I49.1	I49.49
I49.2	I49.5	R06.00	R06.01	R06.02	R06.09	R07.2
R07.9	R07.89

Covered Diagnosis Codes for procedure codes 33285, 33286, 93228, 93229, 93268, 93270, 93271, 93272, 93285, 93291, 93297, 93298, and E0616

I45.9	I45.81	I49.8	I49.9	I49.40	R00.1	R00.2
R42	R55

Covered Diagnosis Codes for procedure codes 33285, 33286, 93285, 93291,93297, 93298, and E0616

G45.9	I63.81	I63.89	I63.9	I63.50	I63.59	I63.313
I63.323	I63.333	I63.343	I63.413	I63.423	I63.433	I63.511
I63.512	I63.519	I63.521	I63.522	I63.529	I63.531	I63.532
I63.539	I63.541	I63.542	I63.549	I67.841	I67.848	Z45.09
Z86.73	Z95.818

Covered Diagnosis Codes for procedure codes 93228, and 93229

121.11	I20.8	I21.01	I21.02	I21.09	I21.9	I21.A1
I21.A9	I22.0	I22.1	I22.9	I24.1	I24.8	I24.9
I25.2	I25.5	I25.6	I49.2	R00.0	R00.8	R00.9
Z82.49	Z86.74

Professional Statements and Societal Positions Guidelines

Not Applicable

ND Committee Review

Internal Medical Review Committee 9-26-2019 Coding update only

Internal Medical Review Committee 3-16-2020 Coding update only

Internal Medical Review Committee 9-21-2020 Annual Review

Internal Medical Review Committee 1-19-2021 Coding update: Removed 0295T, 0296T, 0297T, AND 0298T and Added 93241, 93242, 93243, 93244, 93245, 93246, 93247, AND 93248

Internal Medical Review Committee 7-22-2021 Coding update: Added 0650T, Effective date July 01, 2021

Links

References (PDF)

Disclaimer

Current medical policy is to be used in determining a Member's contract benefits on the date that services are rendered. Contract language, including definitions and specific inclusions/exclusions, as well as state and federal law, must be considered in determining eligibility for coverage. Members must consult their applicable benefit plans or contact a Member Services representative for specific coverage information. Likewise, medical policy, which addresses the issue(s) in any specific case, should be considered before utilizing medical opinion in adjudication. Medical technology is constantly evolving, and the Company reserves the right to review and update medical policy periodically.

Policy ID: M-50-032

Section: Diagnostic Medical

Effective Date: July 01, 2018

Revised Date: October 01, 2019

Last Reviewed: September 21, 2020

Archived Date: December 31, 2020

Description

Ambulatory Cardiac Monitors:

Monitors activated only when triggered by the individual:

These monitors are often referred to as event monitors. The two (2) basic types are:
- Looping memory monitor: activated by pushing a button; stores data from before and during symptom occurrence, prior to when it was activated; if activated immediately after a syncopal episode, it will record from the time before the event;
- Symptom event monitor: activated by pushing a button; does not store data prior to when it was activated.

ZIO Patch:

Mobile Cardiac Outpatient Telemetry (MCOT):

A type of loop monitor that is auto-triggered by rhythm changes and also can be triggered by the individual. It is commonly ordered for 14 or 30 day periods.

Implantable Cardiac Monitor:

A monitor implanted under the skin that can monitor continuously and can be triggered by the individual; it may be implanted for several years.

Criteria

Coverage is subject to the specific terms of the member’s benefit plan.

Ambulatory Cardiac Monitors

Quantity Level Limits (QLL)

Ambulatory event monitors may be considered medically necessary once in a 30 day period regardless of the number of events or recordings which occurred. Ambulatory event monitors are considered part of the global allowance and are not eligible for separate reimbursement when performed more frequently within the 30 day period.
Ambulatory event monitors for greater than 30 consecutive days in a twelve (12) month period must be referred for a medical necessity determination. An additional 30 consecutive days may be considered medically necessary in EITHER of the following situations:
- After treatment has been initiated, the symptoms continue to occur; or
- No symptoms occurred during the initial 30 day use of the recorder.

Additional use greater than 30 consecutive days can be made only if documentation can establish the medical need for the frequency.

Procedure Codes

93268

93270

93271

93272

Ambulatory Cardiac Monitoring (ZIO Patch) and Event Monitors

Individuals who experience infrequent symptoms (less frequently than every 48 hours) suggestive of cardiac arrhythmias (i.e., palpitations, dizziness, presyncope, or syncope); or
Individuals with atrial fibrillation (AF) who have been treated with catheter ablation and in whom discontinuation of systemic anticoagulation is being considered.

Procedure Codes

0295T

0296T

0297T

0298T

Mobile Cardiac Outpatient Telemetry (MCOT)

MCOT is limited to a select population and may be considered medically necessary when ALL of the following are met:

The individual has failed the following:
- 48 hour Holter monitor AND/OR it is felt that longer monitoring is necessary; and
- ZIO patch; or
- Individual-triggered event monitor; or
The individual’s condition is such that a Holter monitor OR an event monitor OR a Zio Patch is NOT adequate to make a diagnosis. An explanation must be provided as to why ONLY the MCOT would be sufficient; and
There is low likelihood of a malignant cardiac event; and
Individuals who experience infrequent symptoms (less than every 24-48 hours) suggestive of cardiac arrhythmias (i.e., palpitations, dizziness, presyncope, or syncope); and
It is anticipated that the results of this service would provide diagnostic and treatment information; and

ANY of the following:

Individuals who require monitoring for known, non-life-threatening arrhythmias, such as AF, other supra-ventricular arrhythmias, evaluation of various bradyarrhythmias and intermittent bundle branch block; or
Individuals recovering from cardiac surgery who have documented atrial arrhythmias; or
Individuals with symptomatic underlying structural disease; or
Individuals with no structural heart disease but have recurrent severe symptoms (i.e., recurrent syncope), all testing is negative and an implantable event recorder is contemplated; or
Individuals with unexplained syncope, near syncope, or episodic dizziness; or
Individuals with unexplained recurrent palpitations; or
Individuals with unexplained recurrent shortness of breath; or
Individuals with unexplained recurrent chest pain; or
Individuals with a history of acute myocardial infarction (MI); or
Individuals who require evaluation of antiarrhythmic drug therapy.

Contraindications

Real-time outpatient cardiac monitoring is contraindicated for individuals at high risk of developing sustained ventricular tachycardia or ventricular fibrillation and/or would be more appropriately cared for in a hospital setting.
The MCOT is not indicated for individuals with mild to moderate symptoms of "palpitations" or "weakness."
This system is also not indicated for use as a screening tool.

Use of cardiac surveillance and Holter or event monitoring for the same individual on the same day is considered not medically necessary.

The use of MCOT not meeting the criteria as indicated in this policy is considered not medical necessary.

QLL

MCOT is considered not medically necessary when more than one (1) monitoring episode is reported in a 30 day period.
MCOT is considered not medically necessary when more than two (2) monitoring episodes are reported in a (12) month period.

Procedure Codes

93228

93229

Implantable Cardiac Loop Recorder

The implantation and removal of a cardiac loop recorder may be considered medically necessary when an individual meets the following:

The individual has failedthe following:

48 hour Holter monitor AND/OR it is felt longer monitoring is necessary; and
A ZIO patch; or
An individual-triggered event monitor; or
The individual’s condition is such that those devices are not adequate to make a diagnosis and
There is documentation of the following:
- Palpitations; or
- Dizziness; or
- Syncope and collapse; or
- Other transient symptoms which could be due to arrhythmia; or
- Long term cardiac monitoring post cryptogenic stroke or transient ischemic attack (TIA) ; and
- When BOTH of the following criteria are met:
  - A cardiac arrhythmia is suspected as the cause of the symptoms; and
  - EITHER of the following criteria are met:
    - Individuals with heart failure, prior MI or significant ECG abnormalities, noninvasive ambulatory monitoring, consisting of 30- day presymptom external loop recordings or MCOT, fails to establish a definitive diagnosis; or
    - Individuals without heart failure, prior MI or significant ECG abnormalities, symptoms occur so infrequently and unpredictably (less than one (1) per month) that noninvasive ambulatory monitoring (MCOT or external loop recorders) are unlikely to capture a diagnostic ECG.

The use of an implantable cardiac loop recorder not meeting the criteria as indicated in this policy is considered not medically necessary.

QLL

A remote interrogation device evaluation may be considered medically necessary once in 30 days with interim physician analysis and review.

Procedure Codes

33285	33286	93285	93291	93297	93298	E0616
G2066

Implantable Cardiac Loop Recorder for Post Cryptogenic Stroke or TIA

An implantable cardiac loop recorder, for post cryptogenic stroke or TIA, may be considered medically necessary when ALL of the following are met:

Diagnosis of a cryptogenic ischemic stroke or TIA should be based upon evaluation by a neurologist; and
The following standard tests are ALL required to establish diagnosis of cryptogenic stroke:
- Brain MRI or CT; and
- 12 lead ECG for AF detection; and
- 24 hour ECG monitoring for AF detection (e.g. Holter); and
- Transesophageal echocardiography (TEE); and
- CT angiography (head and neck) or magnetic resonance angiography (MRA) (head and neck) to rule out other causes of stroke; and
The individual is greater than or equal to 40 years of age; and
A documented collaborative treatment plan between neurologist and cardiologist; and
A TIA requires additional documentation of speech disturbance or limb weakness.

Not Medically Necessary

Implantable cardiac loop recorders post cryptogenic stroke or TIA are considered not medically necessary if an individual has ANY of the following:

The individual has a known etiology of stroke or TIA (i.e., large artery atherosclerosis, acute small artery occlusion with a lesion less than one (1) cm in diameter by CT or MRI; or
Evidence of high-risk cardiac or aortic arch source of embolism (left ventricular (LV) or left atrial (LA) thrombus) or ”smoke”, emboligenic valvular lesion or tumor, patent foramen ovale (PFO) with extant source of venous thromboembolism, aortic arch plaque greater than three (3) mm thick or with mobile components; or
History of spontaneous deep vein thrombosis (DVT); or
Stroke of other determined cause such as the presence of non-atherosclerotic vasculopathy, hypercoagulable states (must be tested in individuals less than 55 years of age) and hematologic disorders; or
Untreated hyperthyroidism; or
MI less than one (1) month before stroke/TIA; or
Coronary bypass grafting (CABG) less than one (1) month before stroke/TIA; or
Valvular disease requiring immediate surgical intervention; or
Documented history of AF or atrial flutter; or
Presence of PFO and PFO is an indication to start oral anticoagulant therapy in accordance with European Stroke Organization (ESO) guidelines; or
The individual has a permanent indication for anticoagulation; or
The individual has a permanent contraindication for anticoagulation; or
Life expectancy less than one (1) year; or
The individual is indicated for implant with pacemaker, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy (CRT) or implantable hemodynamic monitoring system.

An implantable cardiac loop recorder, for post cryptogenic stroke or TIA not meeting the criteria as indicated in this policy is considered not medically necessary.

Procedure Codes

33285

33286

E0616

Diagnosis Codes

Covered Diagnosis Codes for procedure codes 93268, 93270, 93271, 93272

I25.111	I25.118	I25.119	I25.701	I25.708	I25.709	I25.711
I25.718	I25.719	I25.721	I25.728	I25.729	I25.731	I25.738
I25.739	I25.751	I25.758	I25.759	I25.761	I25.768	I25.769
I25.791	I25.798	I25.799	I46.2	I46.8	I46.9	I47.0
I47.2	I49.3	I49.01	I49.02	I50.1	Q24.6	Q25.21
Q25.29	Q25.40	Q25.41	Q25.42	Q25.43	Q25.44	Q25.45
Q25.46	Q25.47	Q25.48	Q25.49	R06.3	R06.83	R06.89
R07.82	R40.4

Covered Diagnosis Codes for procedure codes 93228, 93229, 93268, 93270, 93271, 93272

I20.1	I20.8	I20.9	I44.0	I44.1	I44.2	I44.4
I44.5	I44.7	I44.30	I44.39	I44.60	I44.69	I45.0
I45.2	I45.3	I45.4	I45.5	I45.6	I45.10	I45.19
I45.89	I47.1	I47.9	I48.0	I48.11	I48.19	I48.20
I48.21	I48.3	I48.4	I48.91	I48.92	I49.1	I49.49
I49.2	I49.5	R06.00	R06.01	R06.02	R06.09	R07.2
R07.9	R07.89

Covered Diagnosis Codes for procedure codes 33285, 33286, 93228, 93229, 93268, 93270, 93271, 93272, 93285, 93291, 93297, 93298, and E0616

I45.9	I45.81	I49.8	I49.9	I49.40	R00.1	R00.2
R42	R55

Covered Diagnosis Codes for procedure codes 33285, 33286, 93285, 93291,93297, 93298, and E0616

G45.9	I63.81	I63.89	I63.9	I63.50	I63.59	I63.313
I63.323	I63.333	I63.343	I63.413	I63.423	I63.433	I63.511
I63.512	I63.519	I63.521	I63.522	I63.529	I63.531	I63.532
I63.539	I63.541	I63.542	I63.549	I67.841	I67.848	Z45.09
Z86.73	Z95.818

Covered Diagnosis Codes for procedure codes 93228, 93229

121.11	I20.8	I21.01	I21.02	I21.09	I21.9	I21.A1
I21.A9	I22.0	I22.1	I22.9	I24.1	I24.8	I24.9
I25.2	I25.5	I25.6	I49.2	R00.0	R00.8	R00.9
Z82.49	Z86.74

Professional Statements and Societal Positions Guidelines

Not Applicable

ND Committee Review

Internal Medical Review Committee 9-26-2019 Coding update only

Internal Medical Review Committee 3-16-2020 Coding update only

Internal Medical Review Committee 9-21-2020 Annual Review

Links

References (PDF)

Disclaimer

Current medical policy is to be used in determining a Member's contract benefits on the date that services are rendered. Contract language, including definitions and specific inclusions/exclusions, as well as state and federal law, must be considered in determining eligibility for coverage. Members must consult their applicable benefit plans or contact a Member Services representative for specific coverage information. Likewise, medical policy, which addresses the issue(s) in any specific case, should be considered before utilizing medical opinion in adjudication. Medical technology is constantly evolving and the Company reserves the right to review and update medical policy periodically.

Our Partners in Health:
Members
Employers
Producers

Fargo (Headquarters)
4510 13th Ave. S.
Fargo, North Dakota 58121

Medical Policies Quick Search

Stay updated on HealthCare News